![肿瘤药物治疗方案及综合评价](https://wfqqreader-1252317822.image.myqcloud.com/cover/13/43604013/b_43604013.jpg)
上QQ阅读APP看本书,新人免费读10天
设备和账号都新为新人
局部晚期头颈部鳞状细胞癌同步放化疗方案
![](https://epubservercos.yuewen.com/B8A9D8/22919013101368106/epubprivate/OEBPS/Images/T19_211_2490_2013_2853_147064.jpg?sign=1739341884-yxQBXi05m9eT2KE6TzxeiXsUgwcIwueH-0-9cee3c14fca52594423da4ddd89a41fd)
方案评价
![](https://epubservercos.yuewen.com/B8A9D8/22919013101368106/epubprivate/OEBPS/Images/T20_287_344_2030_2817_147065.jpg?sign=1739341884-E2JeANrEoHzDgxsuyOj0Fxw6rGdLHp7H-0-3cad47a76ee833cabb8fb8e84f876e52)
点评
顺铂3周方案(DDP 100mg/m2)较顺铂单周方案(DDP 30mg/m2),为局部晚期头颈部鳞状细胞癌同步放化疗的优选方案,证据来源于Ⅲ期随机对照试验,适用于≤70岁,ECOG PS评分0~2、肌酐清除率≥50ml/min、器官功能良好、未行诱导化疗、计划行同步放化疗的Ⅲ期或Ⅳ期头颈部鳞状细胞癌患者。
(吴 昕 张琼文)
参考文献
[1] VANITA NORONHA,AMIT JOSHI,VIJAY MARUTI PATIL,et al.Once-a-Week versus Once-Every-3-Weeks cisplatin chemoradiation for locally advanced head and neck cancer:a phase Ⅲ randomized noninferiority trial.J Clin Oncol,2018,36:1064-1072.